Author

Fuliang Chu

UT MD Anderson Cancer Center - Cited by 3,222 - Immunology - Cancer - Infectious diseases

Biography

Assistant Professor, Postdoctoral Fellow - University of Texas M.D. Anderson Cancer Center. Instructor at UT MD Anderson Cancer Center - Cancer Prevention Research Training Program.  Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Cancer Immunology Research
Title
Cited by
Year
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
Y Chung, S Tanaka, F Chu, RI Nurieva, GJ Martinez, S Rawal, YH Wang, ...Nature medicine 17 (8), 983-988, 2011201
1100
2011
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
JR Westin, F Chu, M Zhang, LE Fayad, LW Kwak, N Fowler, J Romaguera, ...The lancet oncology 15 (1), 69-77, 2014201
615
2014
Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development
X Liu, X Chen, B Zhong, A Wang, X Wang, F Chu, RI Nurieva, X Yan, ...Nature 507 (7493), 513-518, 2014201
333
2014
The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally …
J Liu, Y Sun, J Qi, F Chu, H Wu, F Gao, T Li, J Yan, GF GaoThe Journal of infectious diseases 202 (8), 1171-1180, 2010201
149
2010
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
D Xu, Z Zhang, L Jin, F Chu, Y Mao, H Wang, M Liu, M Wang, L Zhang, ...European Journal of Clinical Microbiology & Infectious Diseases 24 (3), 165-171, 2005200
132
2005
Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China
T Ya, Q Zhang, F Chu, J Merritt, M Bilige, T Sun, R Du, H ZhangBMC immunology 9, 1-9, 2008200
124
2008
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment
S Rawal, F Chu, M Zhang, HJ Park, D Nattamai, S Kannan, R Sharma, ...The Journal of Immunology 190 (12), 6681-6693, 2013201
96
2013
Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease
F Mao, Q Tu, L Wang, F Chu, X Li, HS Li, W XuOncotarget 8 (23), 38008, 2017201
88
2017
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ...Blood, The Journal of the American Society of Hematology 138 (12), 1081-1085, 2021202
64
2021
Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study.
LJ Nastoupil, JR Westin, NH Fowler, MA Fanale, F Samaniego, Y Oki, ...Journal of Clinical Oncology 35 (15_suppl), 79-79, 2017201
51
2017
First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A* 01 complexed with two immunogenic SIV epitopes and insights into CTL escape
F Chu, Z Lou, YW Chen, Y Liu, B Gao, L Zong, AH Khan, JI Bell, Z Rao, ...The Journal of Immunology 178 (2), 944-952, 2007200
40
2007
Selective targeting of Toll‐like receptors and OX40 inhibit regulatory T–cell function in follicular lymphoma
KS Voo, M Foglietta, E Percivalle, F Chu, D Nattamai, M Harline, ST Lee, ...International journal of cancer 135 (12), 2834-2846, 2014201
39
2014
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity
F Chu, HS Li, X Liu, J Cao, W Ma, Y Ma, J Weng, Z Zhu, X Cheng, Z Wang, ...Leukemia 33 (11), 2640-2653, 2019201
38
2019
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas
J Weng, S Rawal, F Chu, HJ Park, R Sharma, DA Delgado, L Fayad, ...Blood, The Journal of the American Society of Hematology 120 (8), 1613-1623, 2012201
36
2012
Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes
Y Chen, F Gao, F Chu, H Peng, L Zong, Y Liu, P Tien, GF GaoJournal of molecular biology 386 (3), 841-853, 2009200
27
2009
Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome
FS Wang, FL Chu, L Jin, YG Li, Z Zhang, D Xu, M Shi, H Wu, JM MouldsClinical & Experimental Immunology 139 (1), 112-119, 2005200
26
2005
Crystal structure of a bony fish β2-microglobulin: insights into the evolutionary origin of immunoglobulin superfamily constant molecules
W Chen, F Gao, F Chu, J Zhang, GF Gao, C XiaJournal of Biological Chemistry 285 (29), 22505-22512, 2010201
26
2010
HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY
LJ Nastoupil, J Westin, N Fowler, M Fanale, F Samaniego, Y Oki, C Obi, ...Hematological Oncology 35, 120-121, 2017201
23
2017
Versatile CAR T-cells for cancer immunotherapy
F Chu, J Cao, SS NeelalpuContemporary Oncology/Współczesna Onkologia 2018 (1), 73-80, 2018201
23
2018
Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2)
Y Chen, F Chu, F Gao, B Zhou, GF GaoProtein expression and purification 56 (2), 253-260, 2007200
22
2007

Referred From: https://scholar.google.com/citations?user=ctCKYUkAAAAJ&hl=en

Cited by
Citations 3222
h-index 21
i10-index 28
Recommended Journals
Open Access Journals